ScoreWhy is Venus Remedies Ltd ?
1
Company has a low Debt to Equity ratio (avg) at 0 times
2
With a growth in Operating Profit of 96.37%, the company declared Very Positive results in Dec 25
- The company has declared positive results for the last 5 consecutive quarters
- ROCE(HY) Highest at 13.99%
- INVENTORY TURNOVER RATIO(HY) Highest at 6.58 times
- PBDIT(Q) Highest at Rs 37.52 cr.
3
Stock is technically in a Bullish range
- The technical trend has improved from Mildly Bullish on 12-Mar-26 and has generated 22.73% returns since then
- Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
4
With ROE of 10.5, it has a Fair valuation with a 2.4 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 220.39%, its profits have risen by 182.3% ; the PEG ratio of the company is 0.1
5
Increasing Participation by Institutional Investors
- Institutional investors have increased their stake by 0.72% over the previous quarter and collectively hold 4% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Venus Remedies should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Venus Remedies for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Venus Remedies
298.38%
4.14
53.21%
Sensex
-5.44%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.02%
EBIT Growth (5y)
45.72%
EBIT to Interest (avg)
50.94
Debt to EBITDA (avg)
0.54
Net Debt to Equity (avg)
-0.14
Sales to Capital Employed (avg)
1.14
Tax Ratio
23.37%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.00%
ROCE (avg)
9.53%
ROE (avg)
8.61%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
23
Industry P/E
34
Price to Book Value
3.56
EV to EBIT
18.67
EV to EBITDA
15.41
EV to Capital Employed
3.96
EV to Sales
2.95
PEG Ratio
0.13
Dividend Yield
NA
ROCE (Latest)
21.23%
ROE (Latest)
15.49%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Bullish
Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend27What is working for the Company
ROCE(HY)
Highest at 19.85%
NET SALES(Q)
Highest at Rs 259.40 cr
PBDIT(Q)
Highest at Rs 63.42 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 24.45%
PBT LESS OI(Q)
Highest at Rs 56.66 cr.
PAT(Q)
Highest at Rs 47.50 cr.
EPS(Q)
Highest at Rs 35.53
-1What is not working for the Company
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 29.61 cr
Loading Valuation Snapshot...
Here's what is working for Venus Remedies
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 56.66 cr has Grown at 133.36%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 47.50 cr has Grown at 126.2%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Quarterly
Highest at Rs 259.40 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 259.40 cr has Grown at 33.05%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 63.42 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 24.45%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 56.66 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 47.50 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 35.53
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Venus Remedies
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 29.61 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
